Home > Press > Iran Exports Nanodrugs to Syria
Abstract:
Iranian knowledge-based Exir Nano Sina Company presented Sinadoxosome nanodrug to the market in line with the development of nanotechnology in the field of health.
This product is used for the treatment of diseases, including breast and ovarian cancer. In addition to being presented in the country's markets, this nanodrug has been recently exported to Syria.
According to Dr. Mahnaz Qomi, the CEO of Exir Nano Sina Company, 20mg/10ml injective doxorubicin hydrochloride nano-liposomal anticancer drug, commercially known as Sinadoxosome, was produced in Sobhan Oncology Company and presented to the market for the first time in the Middle-East in 2012 after the acquirement of production permit from the Ministry of Health and Medical Education.
This product creates delay in the growth of tumor and increases the life of the patient by eliminating cancerous cells and making small the size of the tumor. The major application of Sinadoxosome is in the treatment of breast cancer, advanced ovarian cancer, multiple myeloma, and Kaposi's sarcoma in the patients who suffer from HIV.
Dr. Qomi underlined the consumers' pleasure with the effectiveness of the drug, and said, "Since the presentation of the drug to the market more than 6,000 vials of Sinadoxosome have been prescribed by oncologists for the treatment of the patients and they have been approved by the oncologists."
According to the producing company, each vial of the similar drug produced in foreign companies is worth $700 in the regional markets while Sinadoxosome is presented at the price of $120.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Trade agreements/Negotiations
Iran Starts Exporting Nano Products to South Korea May 14th, 2016
Iranian Technologists Participate in CHInano 2015 November 4th, 2015
China to Host Iran National Day of Nanotechnology Next Week October 27th, 2015
8th Int'l Iran Nano 2015 Festival Kicks Off Work October 7th, 2015
New-Contracts/Sales/Customers
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020
GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||